MedTrace Logo

Coronary Arteriogenetic Heparinized Exercise

NCT03350737 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2020-05-13

No results posted yet for this study

Summary

This study evaluates the addition of heparin to a 2-week cycle of physical rehabilitation in the treatment of refractory angina. Half of the patients will undergo heparin-primed physical rehabilitation, while the other half will undergo only physical rehabilitation.

Conditions

  • Refractory Angina
  • Chronic Stable Angina

Interventions

OTHER

Physical rehabilitation

Standard treadmill exercise session

DRUG

Heparin

Heparin i.v.

OTHER

Placebo

Sodium Chloride 0.9% i.v.

Sponsors & Collaborators

  • Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy

    collaborator OTHER_GOV

  • Clinical Centre of Serbia

    lead OTHER

Principal Investigators

  • Branko Beleslin, MD, PhD · Clinical Centre of Serbia

  • Ana Djordjevic-Dikic, MD, PhD · Clinical Centre of Serbia

  • Eugenio Picano, MD, PhD · Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03350737 on ClinicalTrials.gov